Mircera

Active Ingredient(s): Methoxy Polyethylene Glycol-epoetin Beta
FDA Approved: * November 14, 2007
Pharm Company: * HOFFMAN-LA ROCHE
Category: Anemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Mircera Overview

Epoetin beta (rINN) /po.tn/ is a synthetic, recombinant[2] form of erythropoietin, a protein that promotes the production of red blood cells. It is an erythropoiesis-stimulating agent (ESA) that is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Epoetin beta is marketed under the trade name NeoRecormon, among others.[3] Contents 1 Chemistry 2 History 3 See also 4 References 5 External links Chemistry Epoeti...

Read more Mircera Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Epoetin_beta

Recent Mircera Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Methoxy Polyethylene Glycol-epoetin Beta
  • Solution: 0.6mg/kg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Mircera: (15 results)

Sorted by National Drug Code
  • 0004-0401 Mircera 50 ug/.3ml Intravenous Injection, Solution by Genentech, Inc.
  • 0004-0402 Mircera 75 ug/.3ml Intravenous Injection, Solution by Genentech, Inc.
  • 0004-0403 Mircera 100 ug/.3ml Intravenous Injection, Solution by Genentech, Inc.
  • 0004-0404 Mircera 150 ug/.3ml Intravenous Injection, Solution by Genentech, Inc.
  • 0004-0405 Mircera 200 ug/.3ml Intravenous Injection, Solution by Genentech, Inc.
  • 0004-0406 Mircera 250 ug/.3ml Intravenous Injection, Solution by Genentech, Inc.
  • 59353-400 Mircera 30 ug/.3ml Intravenous Injection, Solution by Vifor (International) Inc.
  • 59353-401 Mircera 50 ug/.3ml Intravenous Injection, Solution by Vifor (International) Inc.
  • 59353-402 Mircera 75 ug/.3ml Intravenous Injection, Solution by Vifor (International) Inc.
  • 59353-403 Mircera 100 ug/.3ml Intravenous Injection, Solution by Vifor (International) Inc.
  • 59353-404 Mircera 150 ug/.3ml Intravenous Injection, Solution by Vifor (International) Inc.
  • 59353-405 Mircera 200 ug/.3ml Intravenous Injection, Solution by Vifor (International) Inc.
  • 59353-406 Mircera 250 ug/.3ml Intravenous Injection, Solution by Vifor (International) Inc.
  • 59353-407 Mircera 120 ug/.3ml Intravenous Injection, Solution by Vifor (International) Inc.
  • 59353-408 Mircera 360 ug/.6ml Intravenous Injection, Solution by Vifor (International) Inc.

Other drugs which contain Methoxy Polyethylene Glycol-epoetin Beta or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA